A retrospective, single-center study comparing two neoadjuvant protocols for patients with HER2-positive breast cancer.

被引：0
|
作者：
Itay, Amit
Globus, Opher
Levanon, Keren
Sella, Tal
Bernstein-Molho, Rinat
Rotenberg, Tal Shapira
Oedegaard, Cecilie
Fourey, Dana
Gal-Yam, Einav Nili
机构：
[1] Sheba Med Ctr, Ramat Gan, Israel
[2] Sheba Med Ctr, Or Yeuda, Israel
[3] Sheba Tel Hashomer Med Ctr, Suzanne Levy Gertner Oncogenet Unit, Ramat Gan, Israel
[4] Sheba Med Ctr, Tel Hashomer, Israel
[5] Sheba Tel Hashomer Med Ctr, Breast Oncol Inst, Ramat Gan, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12623
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Retrospective, Single-Center Study Comparing Neoadjuvant ACTHP vs. DCbHP in HER2-Positive Early Breast Cancer Patients
    Itay, Amit
    Globus, Opher
    Levanon, Keren
    Sella, Tal
    Bernstein-Molho, Rinat
    Shapira, Tal
    Oedegaard, Cecilie
    Fourey, Dana
    Yam, Einav Nili Gal
    CANCERS, 2025, 17 (02)
  • [2] Retrospective single-center outcome analysis of neoadjuvant and palliative treatment with dual trastuzumab and pertuzumab in HER2-positive breast cancer.
    Marhold, Maximilian
    Ionce, Lea Roxana
    Christ, Alexandra
    Aretin, Marie-Bernadette
    Sagaster, Verena
    Exner, Ruth
    Wimmer, Kerstin
    Devyatko, Yelena
    Fitzal, Florian
    Steger, Guenther G.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Clinical efficacy of pyrotinib combined with chemotherapy for neoadjuvant treatment in HER2-positive breast cancer: a single-center study
    Wei, Benkai
    Yan, Huanhuan
    Li, Fan
    Shen, Jun
    ANTI-CANCER DRUGS, 2025, 36 (04) : 347 - 354
  • [4] Neoadjuvant single and dual HER2 blockade among patients with localized HER2-positive breast cancer.
    Reynolds, Kerry Lynn
    Cheng, XingXing
    Bhatia, Ashmeet
    Specht, Michelle Connolly
    Smith, Barbara Lynn
    Moy, Beverly
    Bardia, Aditya
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [5] Exploring Therapeutic Challenges in Patients with HER2-Positive Breast Cancer-A Single-Center Experience
    Coca, Ramona
    Moisin, Andrei
    Coca, Rafaela
    Diter, Atasie
    Racheriu, Mihaela
    Tanasescu, Denisa
    Popa, Carmen
    Cerghedean-Florea, Maria-Emilia
    Boicean, Adrian
    Tanasescu, Ciprian
    LIFE-BASEL, 2024, 14 (08):
  • [6] Trastuzumab-related subclinical cardiotoxicity in patients with early stage HER2-positive breast cancer: A retrospective single-center cohort study.
    Aseyev, Olexiy
    Rushton-Marovac, Moira
    Crawley, Freya L.
    Johnson, Christopher
    Dent, Susan Faye
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Association of inflammatory blood markers and pathological complete response in HER2-positive breast cancer: a retrospective single-center cohort study
    Chen, Xiaobin
    Cai, Qindong
    Deng, Lin
    Chen, Minyan
    Xu, Min
    Chen, Lili
    Lin, Yuxiang
    Li, Yan
    Wang, Yali
    Chen, Hanxi
    Liu, Shunyi
    Wu, Jinqiao
    Tong, Xin
    Fu, Fangmeng
    Wang, Chuan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [8] Neoadjuvant treatment for HER2-positive breast cancer
    Takada, Masahiro
    Toi, Masakazu
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [9] Real-world data on T-DM1 efficacy – results of a single-center retrospective study of HER2-positive breast cancer patients
    Max Hardy-Werbin
    Vanesa Quiroga
    Beatriz Cirauqui
    Margarita Romeo
    Eudald Felip
    Iris Teruel
    Juan Jose Garcia
    Carlos Erasun
    Sofia España
    Marc Cucurull
    Elisabeth Montprade
    Juan Carlos Pardo
    Dania Carballo
    Jose Maria Velarde
    Mireia Margeli
    Scientific Reports, 9
  • [10] Real-world data on T-DM1 efficacy - results of a single-center retrospective study of HER2-positive breast cancer patients
    Hardy-Werbin, Max
    Quiroga, Vanesa
    Cirauqui, Beatriz
    Romeo, Margarita
    Felip, Eudald
    Teruel, Iris
    Jose Garcia, Juan
    Erasun, Carlos
    Espana, Sofia
    Cucurull, Marc
    Montprade, Elisabeth
    Carlos Pardo, Juan
    Carballo, Dania
    Maria Velarde, Jose
    Margeli, Mireia
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345